PortfoliosLab logoPortfoliosLab logo
ISIN
US67018T1051
CUSIP
67018T105
IPO Date
Nov 21, 1996

Highlights

Market Cap
$247.11M
Enterprise Value
$346.07M
EPS (TTM)
$1.10
PE Ratio
4.57
PEG Ratio
0.01
Total Revenue (TTM)
$1.44B
Gross Profit (TTM)
$998.90M
EBITDA (TTM)
$115.40M
Year Range
$4.92 - $14.62
Target Price
$11.00
ROA (TTM)
3.96%
ROE (TTM)
6.87%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

NUS Performance Chart

Nu Skin Enterprises, Inc. (NUS) is down 47.1% since the beginning of the year. At $5 per share, NUS is trading 65.8% below its 52-week high of $15. Investors who bought $1,000 worth of NUS shares 5 years ago would now be looking at an investment worth $104.


Loading charts...

S&P 500 Index

Returns By Period

Nu Skin Enterprises, Inc. (NUS) has returned -47.13% so far this year and -33.40% over the past 12 months. Over the last ten years, NUS has returned -17.12% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Nu Skin Enterprises, Inc.

1D
-0.40%
1M
-14.83%
YTD
-47.13%
6M
-49.64%
1Y
-33.40%
3Y*
-44.26%
5Y*
-36.42%
10Y*
-17.12%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NUS Monthly Returns History

Based on dividend-adjusted daily data since Nov 22, 1996, NUS's average daily return is +0.03%, while the average monthly return is +0.60%. At this rate, an investment would double in approximately 9.7 years.

Historically, 51% of months were positive and 49% were negative. The best month was Oct 1998 with a return of +67.1%, while the worst month was Jan 2014 at -38.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 7 months.

On a daily basis, NUS closed higher 49% of trading days. The best single day was Mar 19, 2020 with a return of +57.4%, while the worst single day was Oct 4, 2004 at -32.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.29%-19.52%-14.15%0.27%-19.88%-13.64%-47.13%
2025-4.93%21.88%-8.33%-12.81%37.32%-7.42%4.88%45.96%0.16%-12.06%-7.21%-2.73%43.29%
2024-4.43%-32.32%10.64%-14.97%14.04%-21.05%6.45%-19.89%-17.47%-16.01%18.86%-5.62%-63.67%
20231.71%-6.20%-1.33%0.38%-14.58%-0.39%-11.48%-17.35%-11.22%-10.47%-8.29%14.10%-51.07%
2022-5.04%-2.95%3.21%-10.94%10.34%-7.18%0.48%-5.05%-18.49%14.44%10.30%1.08%-13.92%
20215.93%-10.89%3.34%-0.06%14.53%-5.83%-5.23%-5.02%-20.05%-0.79%10.19%15.66%-4.32%

Benchmark Metrics

Nu Skin Enterprises, Inc. has an annualized alpha of -0.48%, beta of 0.86, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since November 22, 1996.

  • This stock participated in 108.48% of S&P 500 Index downside but only 56.82% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-0.48%
Beta
0.86
0.12
Upside Capture
56.82%
Downside Capture
108.48%

Return for Risk

Risk / Return Rank

NUS ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


NUS Risk / Return Rank: 1717
Overall Rank
NUS Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
NUS Sortino Ratio Rank: 1717
Sortino Ratio Rank
NUS Omega Ratio Rank: 1616
Omega Ratio Rank
NUS Calmar Ratio Rank: 2222
Calmar Ratio Rank
NUS Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Nu Skin Enterprises, Inc. (NUS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NUSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.67

Sortino ratioReturn per unit of downside risk

-3.44

Omega ratioGain probability vs. loss probability

0.91

1.37

-0.46

Calmar ratioReturn relative to maximum drawdown

-0.56

2.78

-3.34

Martin ratioReturn relative to average drawdown

-1.13

12.44

-13.57

Dividends

Dividend History

Nu Skin Enterprises, Inc. provided a 4.80% dividend yield over the last twelve months, with an annual payout of $0.24 per share.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%$0.00$0.50$1.00$1.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.24$0.24$0.24$1.56$1.54$1.52$1.50$1.48$1.46$1.44$1.42$1.40

Dividend yield

4.80%2.49%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%

Monthly Dividends

The table displays the monthly dividend distributions for Nu Skin Enterprises, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.06$0.00$0.00$0.06$0.00$0.12
2025$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.24
2024$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.00$0.06$0.00$0.24
2023$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$1.56
2022$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$0.00$0.39$0.00$1.54
2021$0.00$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$0.00$0.38$0.00$1.52

Dividend Yield & Payout


Dividend Yield

Nu Skin Enterprises, Inc. has a dividend yield of 4.80%, which is quite average when compared to the overall market.

Payout Ratio

Nu Skin Enterprises, Inc. has a payout ratio of 21.70%, which is below the market average. This means Nu Skin Enterprises, Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Nu Skin Enterprises, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Nu Skin Enterprises, Inc. was 94.63%, occurring on Jun 17, 2026. The portfolio has not yet recovered.

The current Nu Skin Enterprises, Inc. drawdown is 94.61%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-94.63%Jun 2026
12y 5mo
12y 6moDec 2013 - now
Dot-com crash2000–2002
-86.04%Dec 2000
3y 11mo8y 11mo
12y 10moJan 1997 - Nov 2009
2012 bear market2012
-45.51%Dec 2012
9mo 2d4mo 22d
1y 1moMar 2012 - May 2013
2010 bear market2010
-27.66%Jul 2010
2mo 5d10mo 7d
1y 7dApr 2010 - May 2011
2010 correction2010
-17.12%Jan 2010
1mo 15d1mo 1d
2mo 16dDec 2009 - Mar 2010

Drawdown Indicators


NUSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-94.63%

-56.78%

-37.85%

Max Drawdown (1Y)

Largest decline over 1 year

-60.32%

-9.10%

-51.22%

Max Drawdown (3Y)

Largest decline over 3 years

-83.49%

-18.90%

-64.59%

Max Drawdown (5Y)

Largest decline over 5 years

-89.79%

-25.43%

-64.36%

Max Drawdown (10Y)

Largest decline over 10 years

-92.37%

-33.92%

-58.45%

Current Drawdown

Current decline from peak

-94.61%

-1.80%

-92.81%

Average Drawdown

Average peak-to-trough decline

-48.14%

-10.71%

-37.43%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.67%

2.03%

+27.64%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Nu Skin Enterprises, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Nu Skin Enterprises, Inc. is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for NUS, comparing it with other companies in the Household & Personal Products industry. Currently, NUS has a P/E ratio of 4.6. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for NUS compared to other companies in the Household & Personal Products industry. NUS currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NUS relative to other companies in the Household & Personal Products industry. Currently, NUS has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NUS in comparison with other companies in the Household & Personal Products industry. Currently, NUS has a P/B value of 0.3. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with NUS

Add Nu Skin Enterprises, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with NUS